Organogenesis Holdings Inc.
ORGO
$4.96
$0.142.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.25% | -31.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.51% | -31.55% | |||
| Cost of Revenue | 16.47% | -23.60% | |||
| Gross Profit | 16.52% | -34.14% | |||
| SG&A Expenses | 1.79% | -1.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.64% | -8.21% | |||
| Operating Income | 46.33% | -297.47% | |||
| Income Before Tax | 54.10% | -351.47% | |||
| Income Tax Expenses | 64.81% | -368.99% | |||
| Earnings from Continuing Operations | 50.16% | -345.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.16% | -345.58% | |||
| EBIT | 46.33% | -297.47% | |||
| EBITDA | 60.64% | -208.35% | |||
| EPS Basic | 43.74% | -477.48% | |||
| Normalized Basic EPS | 47.74% | -292.51% | |||
| EPS Diluted | 43.74% | -526.43% | |||
| Normalized Diluted EPS | 47.74% | -296.08% | |||
| Average Basic Shares Outstanding | 0.44% | -2.61% | |||
| Average Diluted Shares Outstanding | 0.44% | -4.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||